RUS      ENG    

Monday, 15 October 2018

HomeAboutInternational Forum of Cardiology and Internal MedicineRussian Cardio AgendaWorld Cardio AgendaEducational projectsGuidelineslinical trialsJournalsNewsArchive

  • FDA Approves Eluvia Paclitaxel-Polymer Stent for PAD ...
  • Indirect Annuloplasty Device Reduces Mitral Regurgitation ...
  • Antihypertensive Therapy Reduces Alzheimer"s, Dementia Risk ...
  • Studies Find No Easy Predictors of Stroke Prevention in TAVR ...

    The Department of Health in Moscow
    The State Committee on Health
    Silicea-Poligraf, publishing house

    Follow us:
    @moscowcardio               Facebook

     <<  return


    Results of the European Congress of Cardiology 2018

     The next annual congress of the European Society of Cardiology was held August 25-29, 2018 inMunich (Germany). The Congress of the European Society of Cardiology is one of the three most important and most visited cardiological international scientific events. More than 31 thousand delegates from 150 countries and 5 continents of the world took part in the work of the Congress.

    As part of the opening ceremony of the Congress of the European Cardiology Society, the ESC president prof. E. Baks presented the president of the Russian society of cardiology, the academician of the RussianAcademy of Sciences Evgeny V. Shlyakhto with the gold medal - the highest award of the European cardiological community.

    The scientific program of the Congress of the European Society of Cardiology was extensive, it included more than 500 symposia and sessions with the participation of both recognized international experts and clinicians and young scientists from different countries. The European Congress covered 400 topics on cardiology and concomitant conditions.

    The most visited scientific sessions of the Congress of the European Society of Cardiology are Hot Line sessions, which traditionally take place in the main hall of the Congress (Munich Hall). This year, 5 sessions of Hot Line and Late-Breaking Clinical Trials were held, which presented the results of new major studies in various areas of cardiology. The results of the long-awaited studies of ARRIVE (Aspirin to Reduce Risk of Initial Vascular Events), ASCEND (A randomized trial of aspirin versus placebo for primary cardiovascular prevention in 15,480 people with diabetes), ASCEND (A randomized trial of omega-3 fatty acids oil) versus placebo for primary cardiovascular prevention in 15,480 people with diabetes), COMMANDER HF (Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following, Episode of Decompensated Heart Failure, GLOBAL LEADERS TRIAL (A randomized comparison of 24 month ticagrelor and 1 month aspirin versus 12 month antiretroviral therapy followed by aspirin monotherapy, PURE (Association of dietary quality and risk of cardiovascular disease and mortality in more than 218,000 people from over 50 countries).

    Of great interest was the dynamically developing direction "Digital Medicine", in which 16 symposiums were held in total.

    This year a large number of joint symposiums were presented in the scientific program. Thus, 32 joint symposia were held with international and national societies of the countries of North, South Africa, Asia, as well as European societies of other profiles. The world-famous cardiac journals (the European Heart Journal, Circulation, The New England Journal of Medicine, JAMA, The Journal of the American College Cardiology) organized 10 symposia.

    It is noteworthy that 10 educational sessions on general issues of cardiology, emergency care, interventional cardiology, electrophysiology / ablation, medical statistics, clinical studies and algorithms for establishing a clinical diagnosis were organized for young cardiologists-future scientists.

    Within the framework of the scientific program, real-time broadcasting of procedures for interventional interventions from international educational centers in Italy, England, Germany and Spain was organized.

    The scientific program included satellite symposiums with the participation of international manufacturers of medicines and medical equipment.

    Poster presentations are an important part of the scientific program. They were conducted in 9 directions in two formats: traditional poster sessions and electronic posters.

    The collection of scientific papers includes more than 4,500 abstracts, some of which were selected for oral presentations.

    According to the established tradition, the congress was provided with updated clinical recommendations:

    At the exhibition with the participation of 200 manufacturers of medicines and medical equipment, new achievements in the diagnosis and treatment of cardiovascular diseases were presented.

    A large delegation from the Russian Federation took part in the work of the Congress. Leading Russian scientists acted as oral and poster speakers and co-chairs of symposia. The works of young Russian scientists were awarded prizes and awards. The Russian Cardiological Society took part in the exhibition of national cardiological societies.

    More information about the congress of the European Society of Cardiology is available on its official website

    The review of new European clinical recommendations and the results of major international studies presented at the congress of the European Society of Cardiology will be published in early October 2018 on the official website of the Cardioprogress Fund

    The next congress of the European Society of Cardiology is scheduled to be held in Paris (France) from August 31 to September 4, 2019.


    Contact us: by  

    Main | About | International Forum of Cardiology and Internal Medicine | Russian Cardio Agenda | World Cardio Agenda | Educational projects | Guidelines | linical trials | Journals | News | Archive
    2012-2018. Foundation for Promotion of Cardiology